S&P 500 7,811.54 +0.59%Nasdaq 27,366.17 +0.64%Dow 51,654.95 +0.83%Russell 2000 2,806.98 +0.46%as of 2026-10-09 close
▚ The MicroCap Herald
Micro-cap and nano-cap intelligence, before the crowd
Market Pulse

Four Micro-Cap Consolidations Across Three Sessions Cut Vision Marine to About 653,000 Shares and Longeveron to About 3.0 Million Class A

Vision Marine, Longeveron and Cycurion each moved this week to consolidate shares and defend a Nasdaq listing. A fourth, OTCQB-quoted GlobalTech, split to try to obtain one. All four left authorized share counts untouched.
Illustrative photograph: stock-market trading screens showing price charts.

Four micro-cap share consolidations were announced this week or take effect between Wednesday and Friday. Three are aimed at keeping a Nasdaq listing; one is aimed at obtaining a listing the company does not have. Every figure below is a share count or a term drawn from the company's own announcement.

Vision Marine: about 653,000 shares outstanding

Vision Marine Technologies' 1-for-10 reverse split took effect at Wednesday's market open, according to an August 24 press release. Shares outstanding fell from approximately 6,530,460 to approximately 653,046, leaving a Nasdaq-listed company with fewer than 700,000 shares outstanding.

The company said "the primary purpose of the reverse stock split is to increase the per-share market price of the Company's common shares in an effort to regain compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market," while adding that "there can be no assurance that the reverse stock split will result in the Company regaining or maintaining compliance with this requirement." The release says the split will "not decrease the number of authorized common shares (which shall remain limitless)." Fractional shares round up to the next whole common share.

A share count of roughly 6.5 million before a 1-for-10 consolidation is itself low for a Nasdaq-listed company. StockTitan's split-history compilation for the ticker, a secondary compilation rather than a company filing, lists earlier consolidations, but the entries the Herald retrieved carry no years that could be confirmed, and one is listed as a 10-for-1 forward split rather than a consolidation. The Herald has not verified any prior Vision Marine split against a company filing, and none is asserted here.

Longeveron: a fractional-share detail worth reading

Longeveron's 1-for-10 reverse split became effective at 11:59 p.m. ET Wednesday, with split-adjusted trading on the Nasdaq Capital Market beginning Thursday, according to an August 24 announcement. Class A shares go from approximately 30,432,974 to approximately 3,043,298 and Class B from approximately 1,449,005 to approximately 144,901, based on counts as of August 6. Authorized shares and par value are unchanged.

The rounding language is specific and worth reading closely. The company said fractional shares "will be rounded up to the nearest whole share at the Depository Trust Company participant level" and that it "will not round up fractional shares at the beneficial ownership level." No cash consideration is paid in lieu. Rounding is therefore applied to the aggregate position held at the participant level, not account by account.

Longeveron said the split is intended "to increase the per share trading price of the Company's Class A common stock to enable the Company to regain compliance with the $1.00 per share minimum bid price requirement." Outstanding warrants exercisable for Class A common stock and all equity awards under the company's equity plans, including option exercise prices and the number of shares issuable, "will be proportionally adjusted to maintain their economic value."

Cycurion: a 1-for-8 effective Friday

Cycurion announced on Wednesday, in a release datelined McLean, Virginia, August 26, a 1-for-8 reverse split effective at the market open on Friday, August 28. The company said the split will take shares outstanding from approximately 25,840,335 to approximately 3,230,041. It has not yet taken effect. The company said the split is "intended to, among other things, assist the Company in maintaining compliance with the minimum bid price requirement for continued listing on The Nasdaq Global Market" — the Global Market, not the Capital Market tier named by Vision Marine and Longeveron. Authorized shares are unchanged. Unlike the other three, Cycurion pays cash rather than rounding up: holders otherwise entitled to a fractional share "will receive a cash payment (without interest and subject to applicable withholding taxes) equal to the fractional share interest multiplied by the closing price of the Company's common stock on The Nasdaq Global Market on the trading day immediately preceding the effective date." The consolidation carries a new CUSIP, 95758L404.

Two further items about Cycurion come from StockTitan's coverage of the company rather than from a company filing the Herald was able to retrieve, and are reported here on that basis: a prior 1-for-30 reverse split recorded as completed October 27, 2025, and an August 7 item confirming an August 20 Nasdaq hearing date. The Herald was not able to retrieve any document disclosing the outcome of that August 20 hearing. No outcome is asserted or implied here, and readers should not infer one from the fact that the company has scheduled this consolidation.

The outlier

The fourth consolidation runs the other direction. GlobalTech Corp, quoted on the OTCQB, took its 1-for-3 reverse split effective Thursday, cutting approximately 152 million shares to approximately 50 million. Its August 25 Form 8-K says the split will "likely be necessary to obtain a listing" on the Nasdaq Capital Market and that the company has "not yet been approved to list" and does "not currently meet all of the requirements for uplisting."

The common thread, and the risk

In every one of the four cases the authorized share count was left untouched while the outstanding count was cut. Vision Marine's authorized common shares remain, in the company's word, limitless; Longeveron, Cycurion and GlobalTech each stated that authorized totals do not change. For the three with a fixed authorized number, the practical effect is materially more unissued authorized capacity relative to shares outstanding than a week ago, which is the capacity available for future dilutive issuance. None of the four announcements demonstrates that a consolidation resolves the condition that produced the listing deficiency in the first place.

A reverse split raises a quoted price mechanically. It does not add revenue, cash or stockholders' equity, and three of these four companies are consolidating precisely because their shares have traded below $1.00. No closing prices appear in this article: U.S. markets were open at the time of publication, and every figure above is a share count or a term drawn from a company announcement rather than from trading data. All four announcements were read through StockTitan's news pages rather than the originals filed with regulators.

This article is for general information only and is not investment advice. Figures are as reported by the cited sources at time of writing.

Related coverage

Illustrative photograph: US banknotes and coins.
Market Pulse

Eleven Small-Company Reverse Splits Took Effect Between Sept. 28 and Oct. 8, From 1-for-10 to 5,000-for-1. Under Nasdaq Rule 5810(c)(3)(A)(iv), Each of the Seven Nasdaq Names on the List Has No Cure Period if Its Bid Fails the $1 Test Within a Year.

8-Ks on EDGAR show seven Nasdaq, two NYSE American and two OTC consolidations among the micro- and small-caps we tracked, with two more Nasdaq splits set for Oct. 12; the list is not exhaustive. Vivakor's 1-for-15 follows a 1-for-20 in July, a cumulative 300-to-1 by our arithmetic, above the rule's 250-to-1 two-year threshold.

Wesley Stroud · October 10, 2026
Illustrative photograph: a printed financial chart and market data.
Market Pulse

The Russell 2000 Was the Only Major Index to Fall in the Week to Oct. 9, Down 0.91%, While the Micro-Cap ETF Lost 1.97% and Three IPOs Priced, One of Them a SPAC

TheStreet's 4 p.m. wrap put the Russell 2000 at 2,808.57 on Friday; Nasdaq's historical table shows the iShares Micro-Cap ETF closing at 183.00, from 186.68 a week earlier. Renaissance Capital counted two biotech IPOs and one blank-check pricing, plus ten new filings, in the week of Oct. 5.

Wesley Stroud · October 10, 2026
Illustrative photograph: stock-market trading screens showing price charts.
Market Pulse

bioAffinity clears two Nasdaq deficiencies and its hearing is cancelled, leaving about 592,373 shares outstanding

A Nasdaq letter dated Sept. 8 confirmed compliance with both the minimum bid price rule and the rights-and-warrants rule, cancelling a Hearings Panel appearance the company had been pushed into because a reverse split within the prior year disqualified it from any cure period. Two splits in eleven months compound to 450-to-1, above the 250-to-1, two-year threshold written into the same rule.

Wesley Stroud · September 10, 2026